Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
Lead a distributed, multi-institutional Parkinson's research network with NIH support for novel discovery and optional clinical validation.
Report stale or inaccurate summary
What this is
The Morris K. Udall Discovery Centers without Walls (DCWoW) program funds distributed, collaborative research networks studying Parkinson's disease mechanisms and treatments. The RM1 mechanism allows flexible research designs with the option to incorporate clinical trials. This is NIH funding (CFDA 93.853) aimed at catalyzing multi-institutional research teams rather than single-site laboratories, though specific budget ranges and application details were not provided in this notice.
Who can apply
Eligibility criteria were not specified in this notice. Typically, NIH RM1 mechanisms support institutions (universities, medical centers, non-profits) with research capacity; solo founders and small startups are rarely eligible unless partnered with an established research institution.
Topics: parkinson's disease research · NIH funding · collaborative research centers · neurodegenerative disease · clinical research networks
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.